Failure to Win the Contract for the Generic Drug Notification Service for the Japan Health Insurance Association
First written in FY2017-Q3. 3 of 5 entries say "Restated". Latest entry: FY2020.
No other company in this theme has enough history to compare yet.
- FY2020DroppedAnnual report
「The principal risks are as follows.」
The loss of the generic-drug notification service contract for the National Health Insurance Association is not listed among the major risks individually identified for the fiscal year. - FY2020-Q2RestatedAnnual report
「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
Discloses that there have been no new developments or material changes in the risk related to losing the generic-drug notification service contract for the National Health Insurance Association. - FY2019-Q3RestatedAnnual report
「No new business or other risks arose during the cumulative third quarter under review. In addition, there have been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
Discloses that there have been no new developments or material changes in the risk related to losing the generic-drug notification service contract for the National Health Insurance Association. - FY2019-Q2RestatedAnnual report
「During the first six months of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
Discloses that there have been no new developments or material changes in the risk related to losing the generic-drug notification service contract for the National Health Insurance Association. - FY2017-Q3MaterialisedAnnual report
「While the business for National Health Insurance expanded steadily, the company lost the National Health Insurance Association's generic-drug notification service contract during the fiscal year, resulting in a substantial decline in revenue from Kyokai Kenpo.」
States that the company lost the generic-drug notification service contract for the National Health Insurance Association, resulting in a substantial decline in revenue from Kyokai Kenpo.